Eli Lilly is a market darling at the moment because of its industry-leading GLP-1 drugs. The stock looks priced for perfection despite a well-known drug cycle. That's good news, but investors are well ...
Forget the drug discovery hype. Here’s how the world’s largest pharma company is seeing a payoff from AI right now. There’s been huge hype around AI’s potential for drug discovery. But at Eli Lilly, ...
Eli Lilly & Co will invest $3 billion in China over the next decade to expand local production, with a focus on weight loss as the US drugmaker looks to cement its dominance in the booming obesity ...
Eli Lilly stock is down 13% from its 52-week high. Analysts still see some decent upside for the stock, with its average price target being north of $1,200. The company experienced tremendous growth ...
Eli Lilly is infusing $3 billion into its manufacturing operations in China, pledging to set up local production and supply for oral solid drugs as it works on building out capacity for its ...
SHANGHAI, March 11 (Reuters) - Eli Lilly (LLY.N), opens new tab plans to invest $3 billion in China over the next decade, which will help build production capacity for its experimental type-2 ...
CHONGQING, CHINA - JANUARY 29: In this photo illustration, a smartphone displays the logo of Eli Lilly and Company (NYSE: LLY), a U.S.-based pharmaceutical company specializing in prescription ...
Announcing the submission of a marketing application for its experimental weight loss drug, orforglipron, in China, Eli Lilly (LLY) said on Wednesday that it plans to invest $3B in the country over ...
Decorated in soft lighting and wooden accents, Kin Clothing Exchange is curated in a chaotic yet familiar style, evoking the ...
Eli Lilly stock is down 13% from its 52-week high. Analysts still see some decent upside for the stock, with its average price target being north of $1,200. The company experienced tremendous growth ...
Novo Nordisk shares sank after the Danish drugmaker suffered a setback in its battle with Eli Lilly to dominate the market for weight-loss drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results